MedTrace Logo

Renal Replacement Anticoagulant Management

NCT03545750 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 85000

Last updated 2019-11-25

No results posted yet for this study

Summary

Observational comparative effectiveness study of individual patient data using interrupted time series analysis techniques of linked data sources to establish clinical and health economic effects of moving from systemic heparin anticoagulation to regional citrate anticoagulation during continuous renal replacement therapy (CRRT) for patients treated on non-specialist Intensive Care Units (ICUs) in England and Wales.

Conditions

  • Critical Illness

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • Royal Surrey County Hospital NHS Foundation Trust

    collaborator OTHER

  • University of Bristol

    collaborator OTHER

  • Intensive Care National Audit & Research Centre

    lead OTHER

Principal Investigators

  • Peter Watkinson, MD · University of Oxford

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545750 on ClinicalTrials.gov